Impact BioMedical, Inc. (IBO)
0.4602
+0.02
(+4.35%)
USD |
NYAM |
Sep 11, 16:00
0.4598
0.00 (0.00%)
After-Hours: 07:06
Impact BioMedical Price to Book Value : 4.609 for Sept. 11, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 11, 2026 | 4.609 |
| September 10, 2026 | 4.417 |
| September 09, 2026 | 4.944 |
| September 08, 2026 | 5.008 |
| September 04, 2026 | 5.408 |
| September 03, 2026 | 4.807 |
| September 02, 2026 | 4.907 |
| September 01, 2026 | 4.587 |
| August 31, 2026 | 4.618 |
| August 28, 2026 | 4.444 |
| August 27, 2026 | 4.417 |
| August 26, 2026 | 4.408 |
| August 25, 2026 | 4.609 |
| August 24, 2026 | 4.537 |
| August 21, 2026 | 4.807 |
| August 20, 2026 | 4.500 |
| August 19, 2026 | 4.338 |
| August 18, 2026 | 4.707 |
| August 17, 2026 | 4.781 |
| August 14, 2026 | 4.600 |
| August 13, 2026 | 4.407 |
| August 12, 2026 | 4.477 |
| August 11, 2026 | 4.306 |
| August 10, 2026 | 4.362 |
| August 07, 2026 | 4.358 |
| Date | Value |
|---|---|
| August 06, 2026 | 4.515 |
| August 05, 2026 | 4.306 |
| August 04, 2026 | 4.407 |
| August 03, 2026 | 4.397 |
| July 31, 2026 | 4.306 |
| July 30, 2026 | 4.306 |
| July 29, 2026 | 4.271 |
| July 28, 2026 | 4.306 |
| July 27, 2026 | 4.326 |
| July 24, 2026 | 4.407 |
| July 23, 2026 | 4.310 |
| July 22, 2026 | 4.310 |
| July 21, 2026 | 4.417 |
| July 20, 2026 | 4.457 |
| July 17, 2026 | 4.567 |
| July 16, 2026 | 4.567 |
| July 15, 2026 | 4.607 |
| July 14, 2026 | 4.807 |
| July 13, 2026 | 4.637 |
| July 10, 2026 | 4.427 |
| July 09, 2026 | 4.532 |
| July 08, 2026 | 4.524 |
| July 07, 2026 | 4.524 |
| July 06, 2026 | 4.777 |
| July 02, 2026 | 4.727 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| LENZ Therapeutics, Inc. | 0.6476 |
| Enveric Biosciences, Inc. | 0.6915 |
| ANI Pharmaceuticals, Inc. | 2.700 |
| Corcept Therapeutics, Inc. | 17.25 |
| Veru, Inc. | 1.466 |
Price to Book Value Related Metrics
| PS Ratio | 1092.69 |
| Price | 0.4602 |
| Earnings Yield | -21.34% |
| Market Cap | 49.62M |